StockClub
CMOPFCosmo Pharmaceuticals N.V.$ --
Cosmo Pharmaceuticals N.V.

Cosmo Pharmaceuticals N.V.

CMOPF

$ -

-

You can review earnings summary, quarterly trends, full-year progress, and detailed income statement data.

analyticsIncome Statement Summary

FY2025 Full YearUpdated: 12/31/2025

Revenue

attach_money
105M EUR
YoY -60.7%

Operating Income

bar_chart
-10M EUR
YoY -107.0%

Net Income

verified
-4M EUR
YoY -102.7%

EPS

pie_chart
-0.23EUR
YoY -102.8%

Quarterly Performance

Quarterly revenue and net income trend

RevenueOperating IncomeNet Income
No quarterly data available

Full-Year Progress

FY2025
Net Income Progress1481.6%On Track
Revenue Progress104.2M
Revenue Forecast102.2M
Net Income Progress-3.6M
Net Income Forecast-243,668

Income Statement Details

Item
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Revenue
Cost of revenue
Gross profit
105
56
49
Research & development
Selling & marketing
Selling, general and administrative
Other operating expenses
Operating income
32
0
27
115
-10
Interest expense
Income before tax
Income tax expense
Net income
0
-1
3
-4

Unlock Long-Term Income Statement Data

Your current plan allows viewing financial data for the latest 1 year (annual only). Upgrade to the Standard Plan to view up to 3 years (including quarterly data), or the Premium Plan to access all historical data.